製品の概要

  • 製品名Tamoxifen citrate
  • 製品の詳細
    Estrogen receptor antagonist and partial agonist
  • 生理活性の詳細Competitive estrogen receptor antagonist and partial agonist. Inhibits estrogen dependent gene transcription and tumor growth. Additionally decreases cardiac infarction and inhibits Kir2.1, Kir2.2 and Kir2.3 potassium channels (IC50 values are 0.93, 0.87 and 0.31 µM, respectively).
  • 精製度> 99%

製品の特性

    Tamoxifen citrate (ab120656) 使用論文

    This product has been referenced in:
    • Ponce-Balbuena D  et al. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions. J Pharmacol Exp Ther 331:563-73 (2009). Read more (PubMed: 19654266) »
    • Massarweh S  et al. Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res 68:826-33 (2008). Read more (PubMed: 18245484) »
    • Mandlekar S & Kong AN Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6:469-77 (2001). Read more (PubMed: 11595837) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120656.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"